Difference between revisions of "Team:UofGuelph/Design"

 
(7 intermediate revisions by 2 users not shown)
Line 98: Line 98:
 
U_of_Guelph--gryphon.jpg" class="guelphImages">
 
U_of_Guelph--gryphon.jpg" class="guelphImages">
  
<h1 class="descSub">Background on Beerstone, FRC and
 
  
OXC</h1>
+
<h1 class="descSub">Immediate Objectives</h1>
<p class="descP">
+
Beerstone is a salt precipitate composed primarily of
+
 
+
calcium oxalate (C<sub>2</sub>CaO<sub>4</sub>). It poses
+
 
+
a large problem in the brewing industry due to its high
+
 
+
insolubility and use of corrosive chemicals for its
+
 
+
effective removal from brewing equipment<sup>1</sup>.
+
<br><br>
+
The reason for the high insolubility of beerstone is
+
 
+
because one of its major components, calcium oxalate
+
 
+
(C<sub>2</sub>CaO<sub>4</sub>), contains a chelator.
+
 
+
Calcium ions in the water react with oxalic acids present
+
 
+
in malt, forming calcium oxalate. When polypeptides found
+
 
+
in beer are incorporated into the oxalate structure, the
+
 
+
precipitate that is formed is known as
+
 
+
beerstone<sup>2,3</sup>. Geographic regions that contain
+
 
+
high levels of calcium in their drinking water, such as
+
 
+
Guelph, Ontario, Canada, can lead to 165g of
+
 
+
C<sub>2</sub>CaO<sub>4</sub> buildup per 1000L batch of
+
 
+
beer<sup>4</sup>.
+
The porous nature of beerstone scale promotes biofilm
+
 
+
formation from the microorganisms present in the brewing
+
 
+
solution. Biofilm growth causes both “off flavours” that
+
 
+
can ruin an entire batch of beer and also be a potential
+
 
+
biosafety hazard for the consumer<sup>5</sup>.
+
<br><br>
+
<i>Oxalobacter formigenes</i> is a human gut bacterium
+
 
+
that derives its energy solely from the metabolization of
+
 
+
oxalate using enzymes Formyl-Coenzyme A Transferase (FRC)
+
 
+
and Oxalyl-Coenzyme A Decarboxylase (OXC). Oxalate is
+
 
+
brought into the cell by an oxalate-formate antiporter
+
 
+
(OxIT) and converted to CO2 and formyl-CoA. The formyl-
+
 
+
CoA is reused by FRC as a CoA donor in a subsequent
+
 
+
reaction and released from the cell as formate by
+
 
+
OxIT<sup>6</sup>.
+
</p>
+
 
+
<h1 class="descSub">Objectives</h1>
+
 
<p class="descP">
 
<p class="descP">
 
- Express FRC and OXC in <i>E. coli</i> BL21 using pET28a  
 
- Express FRC and OXC in <i>E. coli</i> BL21 using pET28a  
Line 212: Line 147:
  
 
<p class="descP">
 
<p class="descP">
<i>Saccharomyces cerevisiae</i> is a well characterized expression system for heterologous proteins1. iGEM Guelph proposed the use of an isogenic wildtype <i>S. cerevisiae</i> strain, (W303α) along with two expression systems:
+
<i>Saccharomyces cerevisiae</i> is a well characterized expression system for heterologous proteins<sup>1</sup>. iGEM Guelph proposed the use of an isogenic wildtype <i>S. cerevisiae</i> strain, (W303α) along with two expression systems:
pD1218 that would have frc, oxc and oxit inserted into the plasmid that will allow for the transformed strain (<i>S. cerevisiae-Ox</i>)  to be able to endogenously breakdown oxalate.
+
<br>
pD1218-Full α-MF-frc/oxc that would have two separate plasmids transformed into two separate yeast to heterologously express frc and oxc simultaneously that can then be purified for further characterization.   
+
1. pD1218 that would have <i>frc</i>, <i>oxc</i> and <i>oxit</i> inserted into the plasmid that will allow for the transformed strain (<i>S. cerevisiae-Ox</i>)  to be able to endogenously breakdown oxalate.
 +
<br>
 +
2. pD1218-Full α-MF-<i>frc</i>/<i>oxc</i> that would have two separate plasmids transformed into two separate yeast to heterologously express <i>frc</i> and <i>oxc</i> simultaneously that can then be purified for further characterization.   
 +
<br><br>
 +
pD1218 was used because it is an episomal plasmid that contained<sup>2</sup>:
 +
<br>
 +
1. 2μm, an origin of replication so the cell can maintain a high copy number of pD1218-<i>frc</i>/<i>oxc</i>/<i>oxit</i>.
 +
<br>
 +
2. TEF1, a constitutive promoter that has strong promoter activity in yeasts.
 +
<br>
 +
3. Geneticin-r, resistance to the antibiotic G418 that is the selection marker for yeasts.
 +
<br>
 +
4. pUC, an <i>E. coli</i> ori that allows for immense copies of pD1218 when inserted in <i>E. coli</i>.
 +
<br>
 +
5. Ampicillin-r, <i>E. coli</i> transformed with pD1218 will have resistance to the β-lactam.
 +
<br>
 +
6. CYC1, a 3’ UTR that controls post transcriptional regulation
 +
<br><br><br>
  
pD1218 was used because it is an episomal plasmid that contained 2:
 
2μm, an origin of replication so the cell can maintain a high copy number of pD1218-frc/oxc/oxit.
 
TEF1, a constitutive promoter that has strong promoter activity in yeasts.
 
Geneticin-r, resistance to the antibiotic G418 that is the selection marker for yeasts.
 
pUC, an E. coli ori that allows for immense copies of pD1218 when inserted in E. coli.
 
Ampicillin-r, <i>E. coli</i> transformed with pD1218 will have resistance to the β-lactam.
 
CYC1, a 3’ UTR that controls post transcriptional regulation
 
  
 +
<b>Project 1 - Creating and characterizing <i>S. cerevisiae</i>-Ox</b>
 +
<br><br>
 +
pD1218-<i>frc</i>-<i>oxc</i>-<i>oxit</i> will be made using cloning and this it does not possess any genetic elements that will allow the yeast to endogenously secrete plectasin. Instead, we hope to provide the genetic circuitry to enable it to have the biosynthetic metabolism to break down oxalate <i>in situ</i>.
 +
<br>
 +
After cloning in <i>frc</i>, <i>oxc</i> and <i>oxit</i> into W303α, our developed system will have its biological parameters defined. Important questions to address will be:
 +
<br>
 +
1. At what concentration of oxalate will growth of <i>S. cerevisiae</i>-Ox be inhibited?
 +
<br>
 +
2. What’s the efficiency of the rate of oxalate breakdown by <i>S. cerevisiae</i>-Ox at different sub-inhibitory concentrations?
 +
<br>
 +
Answers can be found using an adapted Minimum Inhibitory Concentration (MIC) assay. It will be carried out to CLSI established guidelines where an initial concentration of oxalate will be dissolved into YPD media and then serially diluted in a 96-well plate. Culture of  <i>S. cerevisiae</i>-Ox will then be diluted to an OD of 0.2 and added to the oxalate-rich media.
 +
<br>
 +
At 24, 48 and 72 hour time points, the OD values will be recorded at each concentration to give values that provide information on the effects of oxalate presence of growth of <i>S. cerevisiae-Ox</i>. An oxalate dissolution test kit from Trinity BioLabs can then be used to measure the rate at which different concentrations of oxalate are broken down by <i>S. cerevisiae</i>-Ox.
 +
<br><br><br>
  
Project 1 - Creating and characterizing <i>S. cerevisiae-Ox</i>
 
pD1218-frc-oxc-oxit will be made using cloning and this it does not possess any genetic elements that will allow the yeast to endogenously secrete plectasin. Instead, we hope to provide the genetic circuitry to enable it to have the biosynthetic metabolism to break down oxalate in situ.
 
After cloning in frc, oxc and oxit into W303α, our developed system will have its biological parameters defined. Important questions to address will be:
 
At what concentration of oxalate will growth of <i>S. cerevisiae-Ox</i> be inhibited?
 
What’s the efficiency of the rate of oxalate breakdown by <i>S. cerevisiae-Ox</i> at different sub-inhibitory concentrations?
 
Answers can be found using an adapted Minimum Inhibitory Concentration (MIC) assay. It will be carried out to CLSI established guidelines where an initial concentration of oxalate will be dissolved into YPD media and then serially diluted in a 96-well plate. Culture of  <i>S. cerevisiae-Ox</i> will then be diluted to an OD of 0.2 and added to the oxalate-rich media.
 
At 24, 48 and 72 hour time points, the OD values will be recorded at each concentration to give values that provide information on the effects of oxalate presence of growth of <i>S. cerevisiae-Ox</i>. An oxalate dissolution test kit from Trinity BioLabs can then be used to measure the rate at which different concentrations of oxalate are broken down by <i>S. cerevisiae-Ox</i>.
 
  
  
 
+
<b>Project 2 - The heterologous expression and protein characterization of <i>frc</i> and <i>oxc</i>.</b>
Project 2 - The heterologous expression and protein characterization of frc and oxc.  
+
<br><br>
 
+
To ensure the secretion of FRC and OXC proteins to extract and measure different expression conditions, further pD1218-based plasmids were developed. These plasmids contained a full α-mating factor (α-MF) leader peptide for secretion with modified Hexahistadine (H6) tags to allow for protein detection using antibody probing.
To ensure the secretion of FRC and OXC to extract and measure different expression conditions, further pD1218-based plasmids were developed. These plasmids contained a full α-mating factor (α-MF) leader peptide for secretion with modified Hexahistadine (H6) tags to allow for protein detection using antibody probing.
+
<br>
 
The additional components used were:
 
The additional components used were:
Full α-MF, an 89aa secretion propeptide from the yeast α mating factor that has protease cleavage sites to naturally cleave off the α-MF protein sequence during protein trafficking.This will allow for secretion of an unmodified form of the protein of interest (POI), plectasin.
+
<br>
α-F Base, a secretion-signal peptide that is naturally cleaved after it aids in translocating the plectasin, to the cell surface.
+
1. Full α-MF, an 89aa secretion propeptide from the yeast α mating factor that has protease cleavage sites to naturally cleave off the α-MF protein sequence during protein trafficking.This will allow for secretion of an unmodified form of the protein of interest (POI), plectasin.
GH6A, a glycine-hexahistidine-alanine tag that was modified to mask the positive charge of the H6-tag to avoid any electrostatic interactions between H6, plectasin or the cytoplasmic membrane
+
<br>
 +
2. α-F Base, a secretion-signal peptide that is naturally cleaved after it aids in translocating the plectasin, to the cell surface.
 +
<br>
 +
3. GH6A, a glycine-hexahistidine-alanine tag that was modified to mask the positive charge of the H6-tag to avoid any electrostatic interactions between H6, plectasin or the cytoplasmic membrane.
 +
<br><br>
  
  
 
In total 2 unique pD1218-based plasmids will be created:
 
In total 2 unique pD1218-based plasmids will be created:
pD1218-full-α-MF-GH6A-frc
+
<br>
pD1218-full-α-MF-GH6A-oxc
+
1. pD1218-full-α-MF-GH6A-<i>frc</i>
 +
<br>
 +
2. pD1218-full-α-MF-GH6A-<i>oxc</i>
 +
<br><br>
  
These plasmids would be transformed and amplified in strains of E. coli DH5α to obtain large amounts of pDNA so that it could have been transformed into the S. cerevisiae strain, W303α.  
+
These plasmids would be transformed and amplified in strains of <i>E. coli</i> DH5α to obtain large amounts of pDNA so that it could have been transformed into the <i>S. cerevisiae</i> strain, W303α.  
 +
<br>
 
The secreted FRC and OXC will be purified using a Ni-NTA column and then characterized by microbroth confrontation assays to assess the optimal ratios needed for efficient breakdown of oxalate.  
 
The secreted FRC and OXC will be purified using a Ni-NTA column and then characterized by microbroth confrontation assays to assess the optimal ratios needed for efficient breakdown of oxalate.  
 +
<br><br><br>
 +
  
1. Thukral, S. K., Chang, K. K. H. & Bitter, G. A. Functional Expression of Heterologous Proteins in Saccharomyces cerevisiae. Methods 5, 86–95 (1993).
 
2. Chan, K.-M., Liu, Y.-T., Ma, C.-H., Jayaram, M. & Sau, S. The 2 micron plasmid of Saccharomyces cerevisiae: A miniaturized selfish genome with optimized functional competence. Plasmid 70, 2–17 (2013).
 
  
  
 
</p>
 
</p>
  
 +
<h1 class="descSub">References</h1>
 +
<p class="descP">
  
 +
 +
1. Thukral, S. K., Chang, K. K. H. & Bitter, G. A. Functional Expression of Heterologous Proteins in Saccharomyces cerevisiae. <i>Methods</i> <b>5</b>, 86–95 (1993).
 +
<br>
 +
2. Chan, K.-M., Liu, Y.-T., Ma, C.-H., Jayaram, M. & Sau, S. The 2 micron plasmid of Saccharomyces cerevisiae: A miniaturized selfish genome with optimized functional competence. <i>Plasmid</i> <b>70</b>, 2–17 (2013).
 +
</p>
  
  

Latest revision as of 01:39, 8 December 2018

Project Design

Immediate Objectives

- Express FRC and OXC in E. coli BL21 using pET28a vector. - Assess the feasibility of using these enzymes as an alternate cleaning method to degrade beerstone.

Project Overview

Step 1: Cloning of frc and oxc into DH5α
-Synthesize frc and oxc
-Add PstI cut site to pET-28a
-Ligate frc and oxc into pET-28a
-Transform pET-28afrc/oxc into DH5α

Step 2: Clone frc and oxc into BL21
-Purify pET-28afrc/oxc from DH5α
-Transform pET-28afrc/oxc into BL21

Step 3: Express and Purify FRC and OXC
-Induce expression with IPTG and extract crude proteins
-Purify proteins using Ni-NTA chromatography

Step 4: Characterize FRC and OXC
-Characterize enzyme function using Sodium Oxalate
-Characterize enzyme function using Calcium Oxalate

Step 5: Design a Cleaning Solution and Test on Beerstone
-Test ability of enzymes to break down Beerstone
-Design a functional cleaning solution

Yeast Project Expansion

Saccharomyces cerevisiae is a well characterized expression system for heterologous proteins1. iGEM Guelph proposed the use of an isogenic wildtype S. cerevisiae strain, (W303α) along with two expression systems:
1. pD1218 that would have frc, oxc and oxit inserted into the plasmid that will allow for the transformed strain (S. cerevisiae-Ox) to be able to endogenously breakdown oxalate.
2. pD1218-Full α-MF-frc/oxc that would have two separate plasmids transformed into two separate yeast to heterologously express frc and oxc simultaneously that can then be purified for further characterization.

pD1218 was used because it is an episomal plasmid that contained2:
1. 2μm, an origin of replication so the cell can maintain a high copy number of pD1218-frc/oxc/oxit.
2. TEF1, a constitutive promoter that has strong promoter activity in yeasts.
3. Geneticin-r, resistance to the antibiotic G418 that is the selection marker for yeasts.
4. pUC, an E. coli ori that allows for immense copies of pD1218 when inserted in E. coli.
5. Ampicillin-r, E. coli transformed with pD1218 will have resistance to the β-lactam.
6. CYC1, a 3’ UTR that controls post transcriptional regulation


Project 1 - Creating and characterizing S. cerevisiae-Ox

pD1218-frc-oxc-oxit will be made using cloning and this it does not possess any genetic elements that will allow the yeast to endogenously secrete plectasin. Instead, we hope to provide the genetic circuitry to enable it to have the biosynthetic metabolism to break down oxalate in situ.
After cloning in frc, oxc and oxit into W303α, our developed system will have its biological parameters defined. Important questions to address will be:
1. At what concentration of oxalate will growth of S. cerevisiae-Ox be inhibited?
2. What’s the efficiency of the rate of oxalate breakdown by S. cerevisiae-Ox at different sub-inhibitory concentrations?
Answers can be found using an adapted Minimum Inhibitory Concentration (MIC) assay. It will be carried out to CLSI established guidelines where an initial concentration of oxalate will be dissolved into YPD media and then serially diluted in a 96-well plate. Culture of S. cerevisiae-Ox will then be diluted to an OD of 0.2 and added to the oxalate-rich media.
At 24, 48 and 72 hour time points, the OD values will be recorded at each concentration to give values that provide information on the effects of oxalate presence of growth of S. cerevisiae-Ox. An oxalate dissolution test kit from Trinity BioLabs can then be used to measure the rate at which different concentrations of oxalate are broken down by S. cerevisiae-Ox.


Project 2 - The heterologous expression and protein characterization of frc and oxc.

To ensure the secretion of FRC and OXC proteins to extract and measure different expression conditions, further pD1218-based plasmids were developed. These plasmids contained a full α-mating factor (α-MF) leader peptide for secretion with modified Hexahistadine (H6) tags to allow for protein detection using antibody probing.
The additional components used were:
1. Full α-MF, an 89aa secretion propeptide from the yeast α mating factor that has protease cleavage sites to naturally cleave off the α-MF protein sequence during protein trafficking.This will allow for secretion of an unmodified form of the protein of interest (POI), plectasin.
2. α-F Base, a secretion-signal peptide that is naturally cleaved after it aids in translocating the plectasin, to the cell surface.
3. GH6A, a glycine-hexahistidine-alanine tag that was modified to mask the positive charge of the H6-tag to avoid any electrostatic interactions between H6, plectasin or the cytoplasmic membrane.

In total 2 unique pD1218-based plasmids will be created:
1. pD1218-full-α-MF-GH6A-frc
2. pD1218-full-α-MF-GH6A-oxc

These plasmids would be transformed and amplified in strains of E. coli DH5α to obtain large amounts of pDNA so that it could have been transformed into the S. cerevisiae strain, W303α.
The secreted FRC and OXC will be purified using a Ni-NTA column and then characterized by microbroth confrontation assays to assess the optimal ratios needed for efficient breakdown of oxalate.


References

1. Thukral, S. K., Chang, K. K. H. & Bitter, G. A. Functional Expression of Heterologous Proteins in Saccharomyces cerevisiae. Methods 5, 86–95 (1993).
2. Chan, K.-M., Liu, Y.-T., Ma, C.-H., Jayaram, M. & Sau, S. The 2 micron plasmid of Saccharomyces cerevisiae: A miniaturized selfish genome with optimized functional competence. Plasmid 70, 2–17 (2013).

University of Guelph iGEM 2018